Mr. McInerney has 25 years of experience in the investment and pharmaceutical industries and has been a member of the Board of Directors since 2008. He is also the Chairman of the Board’s Nomination and Governance Committee as well as a member of the Board’s Audit Committee. Mr. McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specializing in biotechnology and specialty pharmaceutical companies.
Related Articles on Ophthalmology:
Acuity Laser Eye and Vision Center’s Dr. Steven Vale: Eye Surgery Should Be Limited to Physicians
Study: Use Grade 2 Reading Level, DVDs for Cataract Surgery Informed Consent
Nanoparticles to Deliver Steroids to the Retina
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
